N-(2-{4-[6-(2-chlorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]benzamide
Chemical Structure Depiction of
N-(2-{4-[6-(2-chlorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]benzamide
N-(2-{4-[6-(2-chlorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]benzamide
Compound characteristics
Compound ID: | V015-0547 |
Compound Name: | N-(2-{4-[6-(2-chlorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]benzamide |
Molecular Weight: | 577.13 |
Molecular Formula: | C31 H37 Cl N6 O3 |
Salt: | not_available |
Smiles: | Cc1ccccc1C(N(CCN1CCOCC1)CC(N1CCCN(CC1)c1ccc(c2ccccc2[Cl])nn1)=O)=O |
Stereo: | ACHIRAL |
logP: | 3.1624 |
logD: | 3.1563 |
logSw: | -3.6256 |
Hydrogen bond acceptors count: | 8 |
Polar surface area: | 68.966 |
InChI Key: | XHNIFCNIFBUAQS-UHFFFAOYSA-N |